Glenmark gets listed in Dow Jones Sustainability Index
Mumbai: Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, has recently announced that the company has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets for the fourth consecutive year.
DJSI is one of the world's most respected and widely accepted sustainability benchmarks globally with only the top ranked companies in terms of Corporate Sustainability within each industry featured in the index. The DJSI analyses companies on their corporate economic, environmental and social performance, to assess issues such as but not limited to corporate governance, risk management, environmental policy & management systems, supply chain management, occupational health and safety, labor practices, innovation and cyber security amongst others.
Inclusion in this list is considered highly prestigious by global investors, financial analysts and other stakeholders and serves as a benchmark for investors who integrate sustainability considerations into their portfolios.
"Our inclusion in the coveted Dow Jones Sustainability Indices (DJSI) for the fourth consecutive year, is a validation of our commitment to sustainability and reiterates our consistent performance across all sustainability indicators. The DJSI inclusion strengthens our resolve to uphold our sustainability strategy that encompasses the Environmental, Social and Governance (ESG) principles to make a positive difference to our operations, stakeholders, communities and the planet at large," said Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals.
Over 800 companies across sectors from the emerging markets were assessed, out of which around 108 made it to the prestigious index this year including 15 from India. Glenmark is one of the only five companies from the Pharmaceuticals, Biotechnology & Life Sciences sector to be featured in the DJSI Emerging Markets 2021.
